Alteraciones cardiovasculares agudas y síndrome post COVID-19

Abstract

The SARS-CoV-2 virus disease, COVID-19, since its recognition in December 2019 until today has generated multiple challenges to the scientific community. Aspects of the virus, its transmission and pathogenesis are known but there are still elements that are under permanent review and challenge the adaptive capacity of the healthcare system. Most patients have mild symptoms, but a percentage evolve to severe respiratory failure called acute respiratory distress syndrome, which can culminate in septic or cardiogenic shock and death. Patients with underlying cardiovascular comorbidities, such as hypertension, diabetes and coronary artery disease, are more prone to severe coronavirus infection, which requires admission to intensive care units and is associated with increased mortality.   In addition, patients who have had the disease may have persistent symptoms that often require a particular and even multidisciplinary approach because of the impact they have on quality of life.  The aim of this review is to provide available evidence on COVID-19 disease and its short- and long-term cardiovascular consequences, bearing in mind that our understanding of its impact is constantly evolving.   Received for review: June 2021Accepted for publication: October 2021Correspondence: 8 de Octubre 3060. C.P.11600. Montevideo, Uruguay. Tel: (+598) 24876666 int.1810 . Contact e-mail: zulycortellezzi@gmail.com